Kylie Minogue is joining Women Fighting for Herceptin, a British group calling on the National Institute for Clinical Excellence, NICE, to approve Herceptin, a drug used to treat women with HER2/neu receptor positive breast cancer, as a first line treatment for early-stage breast cancer. The group wants the expensive life-saving drug treatment made freely available to all women with HER-2 positive breast cancer. According to Women Fighting for Herceptin, the drug has been around for approximately 10 to 15 years although it has only been prescribed in the UK during the last five to six years, and only for late-stage HER-2 positive breast cancer patients. Approximately 25 percent of women diagnosed with breast cancer are diagnosed with HER-2 positive breast cancer. Women Fighting for Herceptin had invited Minogue to appear at the British group's gala concert last week, but she is still recovering from breast cancer treatments. Minogue was diagnosed with breast cancer last year, and is currently staying with family in Australia.